Search research articles
Contact Us
Filters
Showing results (121-130 of 502) with videos related to
Page
of 51
Sort By:
The Indian Journal of Medical Research
|
November 3, 1998
Importance of RT-PCR for detection of hepatitis C virus among different patient groups
S Ramalingam, P G Babu, G Chandy, et al.
Ophthalmic Surgery and Lasers
|
September 8, 2000
Comparison of low-dose intraoperative mitomycin-C vs 5-fluorouracil in primary glaucoma surgery: a pilot study
L Vijaya, B N Mukhesh, B Shantha, et al.
Journal of Clinical Microbiology
|
September 2, 2000
Hospital-based evaluation of two rapid human immunodeficiency virus antibody screening tests
R Kannangai, S Ramalingam, P K Selvaraj, et al.
Science (New York, N.Y.)
|
October 27, 1995
Nanoscale complexity of phospholipid monolayers investigated by near-field scanning optical microscopy
J Hwang, L K Tamm, Böhm, et al.
International Journal of Dermatology
|
June 11, 2010
Haim Munk syndrome and Papillon Lefevre syndrome--allelic mutations in cathepsin C with variation in phenotype
Reena Rai, S Thiagarajan, Soumya Mohandas, et al.
Cancer Research
|
June 21, 2011
Retinoic acid enhances TRAIL-induced apoptosis in cancer cells by upregulating TRAIL receptor 1 expression
Latha Dhandapani, Ping Yue, Suresh S Ramalingam, et al.
Oncogene
|
October 12, 2021
Induction of SREBP1 degradation coupled with suppression of SREBP1-mediated lipogenesis impacts the response of EGFR mutant NSCLC cells to osimertinib
Zhen Chen, Danlei Yu, Taofeek K Owonikoko, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy
|
October 15, 2010
Molecular structure and vibrational investigation of benzenesulfonic acid methyl ester using DFT (LSDA, B3LYP, B3PW91 and MPW1PW91) theory calculations
P David Suresh Babu, S Periandy, S Mohan, et al.
Oncogene
|
April 17, 2025
Induction of IL6/STAT3-dependent TRAIL expression that contributes to the therapeutic efficacy of osimertinib in EGFR mutant NSCLC cells
You-Take Oh, Zhen Chen, Dongsheng Wang, et al.
Cancer
|
January 19, 2010
Phase 2 study of irinotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer
Suresh S Ramalingam, Judy Foster, William Gooding, et al.
Page
of 51
Search research articles
Search
Showing results (121-130 of 502) with videos related to
Sort By:
Page
of 51
The Indian Journal of Medical Research
|
November 3, 1998
Importance of RT-PCR for detection of hepatitis C virus among different patient groups
S Ramalingam, P G Babu, G Chandy, et al.
Ophthalmic Surgery and Lasers
|
September 8, 2000
Comparison of low-dose intraoperative mitomycin-C vs 5-fluorouracil in primary glaucoma surgery: a pilot study
L Vijaya, B N Mukhesh, B Shantha, et al.
Journal of Clinical Microbiology
|
September 2, 2000
Hospital-based evaluation of two rapid human immunodeficiency virus antibody screening tests
R Kannangai, S Ramalingam, P K Selvaraj, et al.
Science (New York, N.Y.)
|
October 27, 1995
Nanoscale complexity of phospholipid monolayers investigated by near-field scanning optical microscopy
J Hwang, L K Tamm, Böhm, et al.
International Journal of Dermatology
|
June 11, 2010
Haim Munk syndrome and Papillon Lefevre syndrome--allelic mutations in cathepsin C with variation in phenotype
Reena Rai, S Thiagarajan, Soumya Mohandas, et al.
Cancer Research
|
June 21, 2011
Retinoic acid enhances TRAIL-induced apoptosis in cancer cells by upregulating TRAIL receptor 1 expression
Latha Dhandapani, Ping Yue, Suresh S Ramalingam, et al.
Oncogene
|
October 12, 2021
Induction of SREBP1 degradation coupled with suppression of SREBP1-mediated lipogenesis impacts the response of EGFR mutant NSCLC cells to osimertinib
Zhen Chen, Danlei Yu, Taofeek K Owonikoko, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy
|
October 15, 2010
Molecular structure and vibrational investigation of benzenesulfonic acid methyl ester using DFT (LSDA, B3LYP, B3PW91 and MPW1PW91) theory calculations
P David Suresh Babu, S Periandy, S Mohan, et al.
Oncogene
|
April 17, 2025
Induction of IL6/STAT3-dependent TRAIL expression that contributes to the therapeutic efficacy of osimertinib in EGFR mutant NSCLC cells
You-Take Oh, Zhen Chen, Dongsheng Wang, et al.
Cancer
|
January 19, 2010
Phase 2 study of irinotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer
Suresh S Ramalingam, Judy Foster, William Gooding, et al.
Page
of 51